AI for protein design.
Pushing the limits.

Scroll Down

About us

From discovery to design.

We design it from day one, revolutionizing how protein therapeutics are developed.
At Galux, we develope a pioneering protein therapeutics design platform, GaluxDesign, that uniquely integrates artificial intelligence and physical principles.
We bring your imagined proteins to life.

Our platform

GaluxDesign: Integrating physics into AI

Our proprietary AI platform is trained to design proteins from first principles,
resulting in its modality-agnostic nature.

Its unprecedented accuracy has been demonstrated through the de novo design
of antibodies, one of the most challenging protein classes to design.

Latest stories from Galux

Galux and HanAll Biopharma Initiate Strategic Collaboration to Develop AI-Designed Antibody Therapeutics for Cancer
Read More
Pioneering Precision: How South Korea's Galux is Redefining Antibody Discovery with AI
View Article
Korean AI firm Galux develops six novel therapeutic antibodies using innovative design methods
View Article

Join forces with Galux
to lead the next wave of drug innovation.
Together, we push boundaries
and redefine what's possible in medicine.

image